Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

BACKGROUND: BCG vaccination provides incomplete protection against tuberculosis in infants. A new vaccine, modified Vaccinia Ankara virus expressing antigen 85A (MVA85A), was designed to enhance the protective efficacy of BCG. We aimed to assess safety, immunogenicity, and efficacy of MVA85A against...

Descripción completa

Detalles Bibliográficos
Autores principales: Tameris, Michele D, Hatherill, Mark, Landry, Bernard S, Scriba, Thomas J, Snowden, Margaret Ann, Lockhart, Stephen, Shea, Jacqueline E, McClain, J Bruce, Hussey, Gregory D, Hanekom, Willem A, Mahomed, Hassan, McShane, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424647/
https://www.ncbi.nlm.nih.gov/pubmed/23391465
http://dx.doi.org/10.1016/S0140-6736(13)60177-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424647/
https://www.ncbi.nlm.nih.gov/pubmed/23391465
http://dx.doi.org/10.1016/S0140-6736(13)60177-4

Ejemplares similares